STOCK TITAN

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
RxSight, Inc., a leading ophthalmic medical device company, will release its first quarter financial results on May 6, 2024. The company will conduct a conference call to discuss the results at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
RxSight, Inc., azienda leader nel settore dei dispositivi medici oftalmici, pubblicherà i risultati finanziari del primo trimestre il 6 maggio 2024. La società terrà una conferenza telefonica per discutere dei risultati alle 13:30 ora del Pacifico / 16:30 ora dell'Est.
RxSight, Inc., compañía líder en dispositivos médicos oftálmicos, publicará sus resultados financieros del primer trimestre el 6 de mayo de 2024. La empresa realizará una conferencia telefónica para discutir los resultados a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este.
안과 의료 기기 분야의 선도 기업인 RxSight, Inc.는 2024년 5월 6일에 첫 분기 재무 결과를 발표할 예정입니다. 회사는 태평양 시간 오후 1시 30분 / 동부 시간 오후 4시 30분에 결과를 논의하기 위한 컨퍼런스 콜을 진행할 것입니다.
RxSight, Inc., entreprise leader dans le domaine des dispositifs médicaux ophtalmiques, publiera ses résultats financiers pour le premier trimestre le 6 mai 2024. La société organisera une conférence téléphonique pour discuter des résultats à 13h30 heure du Pacifique / 16h30 heure de l'Est.
RxSight, Inc., ein führendes Unternehmen im Bereich der ophthalmologischen Medizingeräte, wird am 6. Mai 2024 die Finanzergebnisse für das erste Quartal veröffentlichen. Das Unternehmen wird um 13:30 Uhr Pazifikzeit / 16:30 Uhr Ostzeit eine Telefonkonferenz zur Erörterung der Ergebnisse abhalten.
Positive
  • None.
Negative
  • None.

ALISO VIEJO, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the first quarter of 2024 after the market close on Monday, May 6, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

To participate in the conference call please register here. While not required, it is recommended that participants join ten minutes prior to the event start time to ensure the necessary audio applications are downloaded and installed. Instructions are provided (including a dial-in option). The call will also be available live and archived for one year at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com


FAQ

When will RxSight, Inc. report its first quarter financial results for 2024?

RxSight, Inc. will report its first quarter financial results on May 6, 2024.

What is RxSight, Inc.'s ticker symbol?

RxSight, Inc.'s ticker symbol is RXST.

At what time will the conference call to discuss the financial results start?

The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on May 6, 2024.

Where can participants access the live and archived version of the conference call?

Participants can access the live and archived version of the conference call at https://investors.rxsight.com/.

RxSight, Inc.

NASDAQ:RXST

RXST Rankings

RXST Latest News

RXST Stock Data

1.43B
38.26M
5.08%
89.48%
7.52%
Medical Devices
Ophthalmic Goods
Link
United States of America
ALISO VIEJO